Literature DB >> 26283207

Resveratrol decreases nitric oxide production by hepatocytes during inflammation.

Charles W Kimbrough1, Jaganathan Lakshmanan1, Paul J Matheson1, Matthew Woeste1, Andrea Gentile1, Matthew V Benns1, Baochun Zhang1, Jason W Smith1, Brian G Harbrecht2.   

Abstract

INTRODUCTION: The production of excessive amounts of nitric oxide (NO) through inducible nitric oxide synthase (iNOS) contributes to organ injury, inflammation, and mortality after shock. Resveratrol (RSV) is a natural polyphenol that decreases shock-induced hepatic injury and inflammation. We hypothesized that RSV would mediate these effects by decreasing hepatocyte iNOS production.
METHODS: Rat hepatocytes were isolated, cultured with varying concentrations of RSV, and then stimulated to induce iNOS with interleukin-1 and interferon. Induction of iNOS protein was measured by Western blot, iNOS mRNA by polymerase chain reaction, and NO production was measured by culture supernatant nitrite. Activation of intracellular signaling pathways involving Akt, c-Jun N-terminal kinase (JNK), and nuclear factor κB (NF-κB) were measured by Western blot using isoform-specific antibodies.
RESULTS: RSV decreased the expression of iNOS mRNA, protein, and supernatant nitrite in a dose-dependent manner. Our previous work demonstrated that Akt and JNK both inhibit hepatic iNOS production, whereas NF-κB increases iNOS expression. Analysis of signaling pathways in this study demonstrated that RSV increased JNK phosphorylation but decreased Akt phosphorylation and increased NF-κB activation.
CONCLUSION: RSV decreases cytokine-induced hepatocyte iNOS expression, possibly through up-regulation of the JNK signaling pathway. RSV merits further investigation to determine its mechanism as a compound that can decrease inflammation after shock.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26283207      PMCID: PMC4567468          DOI: 10.1016/j.surg.2015.07.012

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  32 in total

Review 1.  Inhibition of nitric oxide synthase as a potential therapeutic target.

Authors:  A J Hobbs; A Higgs; S Moncada
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

2.  Resveratrol attenuates hypoxic injury in a primary hepatocyte model of hemorrhagic shock and resuscitation.

Authors:  Rebecca D Powell; Jacob H Swet; Kenneth L Kennedy; Toan T Huynh; Iain H McKillop; Susan L Evans
Journal:  J Trauma Acute Care Surg       Date:  2014-02       Impact factor: 3.313

3.  The modulation of hepatic injury and heat shock expression by inhibition of inducible nitric oxide synthase after hemorrhagic shock.

Authors:  John M Menezes; Chris Hierholzer; Simon C Watkins; Timothy R Billiar; Andrew B Peitzman; Brian G Harbrecht
Journal:  Shock       Date:  2002-01       Impact factor: 3.454

4.  A novel nitric oxide scavenger decreases liver injury and improves survival after hemorrhagic shock.

Authors:  J Menezes; C Hierholzer; S C Watkins; V Lyons; A B Peitzman; T R Billiar; D J Tweardy; B G Harbrecht
Journal:  Am J Physiol       Date:  1999-07

5.  A brief episode of hypotension increases mortality in critically ill trauma patients.

Authors:  Mazen S Zenati; Timothy R Billiar; Ricard N Townsend; Andrew B Peitzman; Brian G Harbrecht
Journal:  J Trauma       Date:  2002-08

6.  A central role for IL-1 beta in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase. IL-1 beta induces hepatic nitric oxide synthesis.

Authors:  D A Geller; M E de Vera; D A Russell; R A Shapiro; A K Nussler; R L Simmons; T R Billiar
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

7.  High absorption but very low bioavailability of oral resveratrol in humans.

Authors:  Thomas Walle; Faye Hsieh; Mark H DeLegge; John E Oatis; U Kristina Walle
Journal:  Drug Metab Dispos       Date:  2004-08-27       Impact factor: 3.922

8.  JNK signaling involved in the effects of cyclic AMP on IL-1beta plus IFNgamma-induced inducible nitric oxide synthase expression in hepatocytes.

Authors:  Baochun Zhang; Michele Perpetua; Melissa Fulmer; Brian G Harbrecht
Journal:  Cell Signal       Date:  2004-07       Impact factor: 4.315

9.  Hepatic dysfunction increases length of stay and risk of death after injury.

Authors:  Brian G Harbrecht; Mazen S Zenati; Howard R Doyle; John McMichael; Ricard N Townsend; Keith D Clancy; Andrew B Peitzman
Journal:  J Trauma       Date:  2002-09

10.  Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock.

Authors:  C Hierholzer; B Harbrecht; J M Menezes; J Kane; J MacMicking; C F Nathan; A B Peitzman; T R Billiar; D J Tweardy
Journal:  J Exp Med       Date:  1998-03-16       Impact factor: 14.307

View more
  5 in total

1.  Aqueous Cichorium intybus L. seed extract may protect against acute palmitate-induced impairment in cultured human umbilical vein endothelial cells by adjusting the Akt/eNOS pathway, ROS: NO ratio and ET-1 concentration.

Authors:  Raziyeh Abdolahipour; Azin Nowrouzi; Masoumeh Babaei Khalili; Alipasha Meysamie; Samin Ardalani
Journal:  J Diabetes Metab Disord       Date:  2020-08-10

2.  Effective inhibition of MERS-CoV infection by resveratrol.

Authors:  Shih-Chao Lin; Chi-Tang Ho; Wen-Ho Chuo; Shiming Li; Tony T Wang; Chi-Chen Lin
Journal:  BMC Infect Dis       Date:  2017-02-13       Impact factor: 3.090

3.  Potential Involvement of Peripheral Leptin/STAT3 Signaling in the Effects of Resveratrol and Its Metabolites on Reducing Body Fat Accumulation.

Authors:  Andrea Ardid-Ruiz; Maria Ibars; Pedro Mena; Daniele Del Rio; Begoña Muguerza; Cinta Bladé; Lluís Arola; Gerard Aragonès; Manuel Suárez
Journal:  Nutrients       Date:  2018-11-14       Impact factor: 5.717

4.  Resveratrol ameliorates renal injury in spontaneously hypertensive rats by inhibiting renal micro-inflammation.

Authors:  Hai-Yan Xue; Li Yuan; Ying-Jie Cao; Ya-Ping Fan; Xiao-Lan Chen; Xin-Zhong Huang
Journal:  Biosci Rep       Date:  2016-06-03       Impact factor: 3.840

Review 5.  Bioactive natural compounds against human coronaviruses: a review and perspective.

Authors:  Yanfang Xian; Juan Zhang; Zhaoxiang Bian; Hua Zhou; Zhenbiao Zhang; Zhixiu Lin; Hongxi Xu
Journal:  Acta Pharm Sin B       Date:  2020-06-08       Impact factor: 11.413

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.